BRIEF published on 05/23/2026 at 00:05, 3 months 1 day ago Redwood AI Collaborates with Resilience Biosciences on AI-Driven Drug Development Drug Development AI Collaboration Redwood AI Resilience BioSciences Small-molecule Discovery
BRIEF published on 05/23/2026 at 00:05, 3 months 1 day ago Redwood AI collabore avec Resilience Biosciences au développement de médicaments piloté par l'IA Développement De Médicaments Collaboration En IA Redwood AI Resilience BioSciences Découverte De Petites Molécules
BRIEF published on 05/22/2026 at 23:06, 3 months 1 day ago Water Ways Technologies Inc. Faces Major Strategic Shift Liquidation Bankruptcy Strategic Review Management Changes Corporate Restructuring
BRIEF published on 05/22/2026 at 23:06, 3 months 1 day ago Water Ways Technologies Inc. est confrontée à un changement stratégique majeur. Liquidation Faillite Revue Stratégique Restructuration D'entreprise Changements De Direction
BRIEF published on 05/22/2026 at 22:20, 3 months 1 day ago NANOBIOTIX lève 100 millions de dollars via une offre globale Biotechnologie Ads Levée De Fonds Cancer NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 3 months 1 day ago NANOBIOTIX raises $100 million through a global offering Biotechnology Fundraising Ads Cancer NANOBIOTIX
BRIEF published on 05/22/2026 at 22:10, 3 months 1 day ago Abivax dévoile ses résultats du T1 2026 et les avancées de l'étude 108 Résultats Financiers Obefazimod Trésorerie RCH Étude 108
BRIEF published on 05/22/2026 at 22:10, 3 months 1 day ago Abivax Reports Q1 2026 Financials and Key Developments in Obefazimod Trials Financial Results Abivax Obefazimod Ulcerative Colitis Clinical Trials
BRIEF published on 05/22/2026 at 22:10, 3 months 1 day ago Abivax unveils its Q1 2026 results and progress on Study 108 Financial Results Treasury Obefazimod RCH Study 108
BRIEF published on 05/22/2026 at 22:10, 3 months 1 day ago Abivax publie ses résultats financiers du premier trimestre 2026 et les principaux développements des essais cliniques de l'obefazimod Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques
Published on 08/24/2026 at 07:45, 3 hours 13 minutes ago Sinopec Achieves Solid Operating Results in the First Half of 2026
Published on 08/22/2026 at 05:50, 2 days 5 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 2 days 6 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 2 days 10 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 2 days 11 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/24/2026 at 10:35, 22 minutes ago Camel Group's 12V Sodium-Ion Battery Selected for European OEM Pre-Development Project
Published on 08/24/2026 at 10:05, 52 minutes ago Jungbunzlauer improves EcoVadis score and remains among the top 2% of companies worldwide
Published on 08/24/2026 at 09:35, 1 hour 22 minutes ago 2026 Taiwan Jewellery & Gem Fair to Take Place in November
Published on 08/24/2026 at 09:00, 1 hour 57 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): Under review
Published on 08/24/2026 at 09:00, 1 hour 57 minutes ago Original-Research: Nabaltec AG (von NuWays AG): BUY
Published on 08/21/2026 at 18:33, 2 days 16 hours ago 260821 BENETEAU Transaction sur actions propres
Published on 08/18/2026 at 18:00, 5 days 16 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 5 days 17 hours ago Mise à disposition du rapport financier annuel 2025-26
